Aclaris Therapeutics Inc. (ACRS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

3.05

-5.43%

After-hours Dec 13, 2024, 07:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	31.25M	29.75M	6.76M	6.48M	4.23M	10.09M	1.68M	-	-	-	-
Cost of Revenue	18.08M	11.96M	4.71M	5.13M	4.05M	6.85M	1.21M	120.00K	90.00K	-	-
Gross Profit	13.17M	17.79M	2.05M	1.35M	172.00K	3.24M	476.00K	-120.00K	-90.00K	-	-
Operating Income	-97.36M	-85.15M	-65.38M	-50.91M	-111.06M	-135.41M	-72.42M	-48.57M	-20.67M	-8.53M	-5.26M
Interest Income	-	-	-	-	-	-	-	-	104.00K	16.00K	21.00K
Pretax Income	-88.85M	-86.91M	-90.86M	-51.34M	-113.54M	-132.74M	-70.35M	-48.08M	-20.56M	-8.52M	-5.24M
Net Income	-88.48M	-88.66M	-114.28M	-51.15M	-142.85M	-132.74M	-68.52M	-48.08M	-20.56M	-8.52M	-5.24M
Selling & General & Admin	31.10M	25.13M	23.62M	20.53M	27.83M	75.65M	33.11M	15.09M	5.33M	2.03M	1.77M
Research & Development	98.38M	77.81M	43.81M	31.73M	64.90M	63.01M	39.79M	33.48M	15.34M	6.51M	3.49M
Other Expenses	-	2.95M	-1.14M	-424.00K	-2.48M	2.68M	2.07M	488.00K	-	-	-
Operating Expenses	130.80M	102.95M	67.43M	52.26M	92.73M	138.66M	72.90M	48.57M	20.67M	8.53M	5.26M
Interest Expense	-	4.70M	-	-	-	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	283.00K	671.00K	48.00M	85.00K	3.29M	-	-	-
Cost & Expenses	128.61M	114.91M	72.14M	57.39M	96.78M	145.50M	74.11M	48.57M	20.67M	8.53M	5.26M
Income Tax	-367.00K	1.75M	23.42M	-182.00K	29.31M	2.68M	-1.83M	-120.00K	-90.00K	-	-
Shares Outstanding (Basic)	69.81M	65.21M	56.73M	42.54M	41.32M	32.91M	28.10M	21.42M	6.11M	10.66M	10.66M
Shares Outstanding (Diluted)	69.81M	65.21M	56.73M	42.54M	41.32M	32.91M	28.10M	21.42M	6.11M	10.66M	10.66M
EPS (Basic)	-1.27	-1.36	-2.01	-1.2	-3.46	-4.03	-2.44	-2.25	-3.37	-0.8	-0.49
EPS (Diluted)	-1.27	-1.36	-2.01	-1.2	-3.46	-4.03	-2.44	-2.25	-3.37	-0.8	-0.49
EBITDA	-117.56M	-84.36M	-65.06M	-48.20M	-90.84M	-80.78M	-53.45M	-48.57M	-20.67M	-8.52M	-5.25M
Depreciation & Amortization	863.00K	797.00K	923.00K	1.32M	1.59M	1.32M	402.00K	120.00K	90.00K	12.00K	11.00K